Characterization of infections of human leukocytes by non-polio enteroviruses

Intervirology

Volumn 55, Issue 5, 2012, Pages 333-341

  Hwang, Jenie Yoonoo ^a   Jun, Eun Jung ^a   Seo, Ilseon ^a   Won, Minna ^a   Ahn, Jeonghyun ^a   Kim, Yoo Kyum ^a   Lee, Heuiran ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Enterovirus infection, cytopathic effects; Leukocyte cell lines; Monocytes; Non polio enterovirus; Receptors; Virus replication

Indexed keywords

VIRUS RECEPTOR;

ARTICLE; B LYMPHOCYTE; CELL DAMAGE; CELL DEATH; CELL LINE; CELL SURFACE; COXSACKIE VIRUS A; COXSACKIE VIRUS B3; CYTOTOXICITY; ENTEROVIRUS INFECTION; HUMAN; HUMAN CELL; LEUKOCYTE; MONOCYTE; PRIORITY JOURNAL; PROGENY; T LYMPHOCYTE; VIRUS LOAD; VIRUS RELEASE; VIRUS REPLICATION;

ADULT; B-LYMPHOCYTES; CELL DEATH; CELLS, CULTURED; CYTOPATHOGENIC EFFECT, VIRAL; ENTEROVIRUS B, HUMAN; ENTEROVIRUS C, HUMAN; ENTEROVIRUS D, HUMAN; HUMANS; MONOCYTES; T-LYMPHOCYTES; VIRUS REPLICATION;

COXSACKIEVIRUS; ENTEROVIRUS; HUMAN ENTEROVIRUS 70; POLIOVIRUS;

EID: 84861454133     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000329987     Document Type: Article

References (41)

1. Vuorinen T, Vainionpaa R, Kettinen H, Hyypia T: Coxsackievirus B3 infection in human leukocytes and lymphoid cell lines. Blood 1994; 84: 823-829.
2. Tebruegge M, Curtis N: Enterovirus infections in neonates. Semin Fetal Neonatal Med 2009; 14: 222-227.
3. Dagan R, Jenista JA, Prather SL, Powell KR, Menegus MA: Viremia in hospitalized children with enterovirus infections. J Pediatr 1985; 106: 397-401.
4. Freistadt MS, Fleit HB, Wimmer E: Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication. Virology 1993; 195: 798-803.
5. Eberle KE, Nguyen VT, Freistadt MS: Low levels of poliovirus replication in primary human monocytes: possible interactions with lymphocytes. Arch Virol 1995; 140: 2135-2150.
6. Vuorinen T, Vainionpaa R, Heino J, Hyypia T: Enterovirus receptors and virus replication in human leukocytes. J Gen Virol 1999; 80: 921-927.
7. Jarasch N, Martin U, Zell R, Wutzler P, Henke A: Influence of pan-caspase inhibitors on coxsackievirus B3-infected CD19+ B lymphocytes. Apoptosis 2007; 12: 1633-1643.
8. Koike S, Ise I, Nomoto A: Functional domains of the poliovirus receptor. Proc Natl Acad Sci USA 1991; 88: 4104-4108.
9. Mena I, Perry CM, Harkins S, Rodriguez F, Gebhard J, Whitton JL: The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol 1999; 155: 1205-1215.
10. Belnap DM, McDermott BM Jr, Filman DJ, Cheng N, Trus BL, Zuccola HJ, Racaniello VR, Hogle JM, Steven AC: Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc Natl Acad Sci USA 2000; 97: 73-78.
11. He Y, Bowman VD, Mueller S, Bator CM, Bella J, Peng X, Baker TS, Wimmer E, Kuhn RJ, Rossmann MG: Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci USA 2000; 97: 79-84.
12. Nilsson EC, Jamshidi F, Johansson SM, Oberste MS, Arnberg N: Sialic acid is a cellular receptor for coxsackievirus A24 variant, an emerging virus with pandemic potential. J Virol 2008; 82: 3061-3068.
13. Alexander DA, Dimock K: Sialic acid functions in enterovirus 70 binding and infection. J Virol 2002; 76: 11265-11272.
14. Haddad A, Nokhbeh MR, Alexander DA, Dawe SJ, Grise C, Gulzar N, Dimock K: Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70. J Virol 2004; 78: 2674-2681.
15. Feederle R, Kost M, Baumann M, Janz A, Drouet E, Hammerschmidt W, Delecluse HJ: The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 2000; 19: 3080-3089.
16. Minor JR, Piscitelli SC: Thalidomide in diseases associated with human immunodeficiency virus infection. Am J Health Syst Pharm 1996; 53: 429-431.
17. Zhou LJ, Tedder TF: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 1996; 93: 2588-2592.
18. Smyth CM, Logan G, Boadle R, Rowe PB, Smythe JA, Alexander IE: Differential subcellular localization of CD86 in human PBMC-derived macrophages and DCS, and ultrastructural characterization by immuno- electron microscopy. Int Immunol 2005; 17: 123-132.
19. Fernandez Pujol B, Lucibello FC, Gehling UM, Lindemann K, Weidner N, Zuzarte ML, Adamkiewicz J, Elsasser HP, Muller R, Havemann K: Endothelial-like cells derived from human CD14-positive monocytes. Differentiation 2000; 65: 287-300.
20. Kempf W, Adams V, Wey N, Moos R, Schmid M, Avitabile E, Campadelli-Fiume G: CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic- sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B. Proc Natl Acad Sci USA 1997; 94: 7600-7605.
21. Graber D, Fossoud C, Grouteau E, Gayet- Mengelle C, Carriere JP: Acute transverse myelitis and coxsackie A9 virus infection. Pediatr Infect Dis J 1994; 13: 77.
22. David P, Baleriaux D, Bank WO, Amrom D, De Temmerman D, Babusiaux C, Matos C, Van Steenwinckel C, Lloret-Pastor C, Szliwowski HB: MRI of acute disseminated encephalomyelitis after coxsackie B infection. J Neuroradiol 1993; 20: 258-265.
23. Whitton JL, Feuer R: Myocarditis, microbes and autoimmunity. Autoimmunity 2004; 37: 375-386.
24. Henke A, Huber S, Stelzner A, Whitton JL: The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 1995; 69: 6720-6728.
25. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N: Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998; 4: 781-785.
26. Tam PE, Weber-Sanders ML, Messner RP: Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy. J Virol 2003; 77: 11849-11854.
27. Triantafyllopoulou A, Tapinos N, Moutsopoulos HM: Evidence for coxsackievirus infection in primary Sjögren's syndrome. Arthritis Rheum 2004; 50: 2897-2902.
28. Chaves SS, Lobo S, Kennett M, Black J: Coxsackie virus A24 infection presenting as acute flaccid paralysis. Lancet 2001; 357: 605.
29. Wahid R, Cannon MJ, Chow M: Dendritic cells and macrophages are productively infected by poliovirus. J Virol 2005; 79: 401-409.
30. Ahn J, Choi J, Joo CH, Seo I, Kim D, Yoon SY, Kim YK, Lee H: Susceptibility of mouse primary cortical neuronal cells to coxsackievirus B. J Gen Virol 2004; 85: 1555-1564.
31. Ahn J, Joo CH, Seo I, Kim D, Kim YK, Lee H: All CVB serotypes and clinical isolates induce irreversible cytopathic effects in primary cardiomyocytes. J Med Virol 2005; 75: 290-294.
32. Jun EJ, Nam YR, Ahn J, Tchah H, Joo CH, Jee Y, Kim YK, Lee H: Antiviral potency of a siRNA targeting a conserved region of coxsackievirus A24. Biochem Biophys Res Commun 2008; 376: 389-394.
33. Chehadeh W, Kerr-Conte J, Pattou F, Alm G, Lefebvre J, Wattre P, Hober D: Persistent infection of human pancreatic islets by coxsackievirus B is associated with -interferon synthesis in cells. J Virol 2000; 74: 10153-10164.
34. Brilot F, Chehadeh W, Charlet-Renard C, Martens H, Geenen V, Hober D: Persistent infection of human thymic epithelial cells by coxsackievirus B4. J Virol 2002; 76: 5260-5265.
35. Feuer R, Ruller CM, An N, Tabor-Godwin JM, Rhoades RE, Maciejewski S, Pagarigan RR, Cornell CT, Crocker SJ, Kiosses WB, Pham-Mitchell N, Campbell IL, Whitton JL: Viral persistence and chronic immunopathology in the adult central nervous system following coxsackievirus infection during the neonatal period. J Virol 2009; 83: 9356-9369.
36. Rossmann MG, He Y, Kuhn RJ: Picornavirus- receptor interactions. Trends Microbiol 2002; 10: 324-331.
37. Karnauchow TM, Tolson DL, Harrison BA, Altman E, Lublin DM, Dimock K: The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J Virol 1996; 70: 5143-5152.
38. Ahn J, Jee Y, Seo I, Yoon SY, Kim D, Kim YK, Lee H: Primary neurons become less susceptible to coxsackievirus B5 following maturation: the correlation with the decreased level of car expression on cell surface. J Med Virol 2008; 80: 434-440.
39. Girn J, Kavoosi M, Chantler J: Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain. J Gen Virol 2002; 83: 351-358.
40. Jarasch-Althof N, Wiesener N, Schmidtke M, Wutzler P, Henke A: Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes. Viral Immunol 2010; 23: 369-376.
41. Takada A, Kawaoka Y: Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol 2003; 13: 387-398.